pristane has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, D; Senouthai, S; Wang, J; You, Y | 1 |
1 other study(ies) available for pristane and vasoactive intestinal peptide
| Article | Year |
|---|---|
Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Topics: Animals; Disease Models, Animal; Female; Lupus Nephritis; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells; Vasoactive Intestinal Peptide | 2019 |